Outer surface protein C of Borrelia stimulates remarkable immune responses during early infection and is currently considered as a leading diagnostic and vaccine candidate. Sensitivity and specificity of serological test based on whole protein OspC is still an issue in the diagnosis of Lyme disease. The minimal B-cell epitopes are key in the development of reliable immunodiagnostic tool. Using OspC fragments displayed on phage particles (phage library) and anti-OspC antibodies isolated from sera of naturally infected patients we identified six OspC epitopes capable of distinguishing between LD patient and healthy control sera. Three epitopes are located at N-terminus (OspC E1 aa19-27, OspC E2 aa38-53, OspC E3 aa62-66) and three at C-terminal end . The OspC E1, E4
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INTRODUCTION
Lyme disease is the most prevalent vector-borne disease in a temperate zone of the Northern hemisphere. It is a progressive multi-systemic disorder caused by members of Borrelia burgdorferi sensu lato complex. Borrelia is able to adapt to different host environments during its enzootic life cycle, which is associated with precise regulation of a variety of genes and expression of a wide repertoire of outer surface proteins (Osp) [1, 2] . Phase variation of two borrelial lipoproteins, OspA and OspC was described as one of the major host adaptation mechanisms [3] . Borrelial virulence factor OspC (~22kDa) is universal among B. burgdorferi sensu lato complex and plays an essential role in vector-host transmission [4] . It provides borreliae with protection from the innate immune system e.g. via binding tick salivary protein Salp15 and facilitates dissemination in the host by binding mammalian plasminogen. However, the precise function of OspC remains controversial [5, 6] . Despite of high amino acid sequence variability of OspC (even among strains collected from a single geographic area), its protein structure is highly conserved [7] . Till to date more than 30 ospC genotypes (phyletic groups differentiated by letters from A to U) have been described in the literature [8, 9] . Correlation between invasive potential of Borrelia and ospC genotype has been discussed previously. For example, four ospC genotypes A, B, I and K were shown to be associated with systemic disease in human [10, 11, 9, 12] .
OspC is highly immunogenic and possess significant diagnostic value as the anti-OspC antibodies (borreliacidal antibodies) developed in high concentrations shortly after infection in human [13, 14] as well as in non-human models [15] . However, in many cases the serological test may fail in early stage of LD because of the inadequately developed antibody response. Repeated blood collection (e.g. a week later) and serological testing based on conserved immunogenic epitopes (like in OspC) would improve the accuracy of serodiagnosis.
Epitope mapping is crucial to determine antibody binding sites important in the development of vaccines, diagnostics and immunotherapeutic compounds. Minimal epitopes, usually spanning minimum six consecutive amino acids, can be reliably mapped by gene-fragment libraries. Single round of panning is usually sufficient to unequivocally determine a linear epitope, which makes gene-fragment phage display libraries a trustworthy tool for mapping of linear epitopes [16] . In this study we present mapping of OspC epitopes with OspC gene fragment library and identification of minimal epitopes that could be used as a component of a LD serological tests with improved capabilities for the diagnosis of LD.
MATERIALS AND METHODS
Lyme disease positive serum samples
The human sera were collected from 89 patients positive for LD with at least one of the following symptoms: erythema migrans (early stage of LD), early neurologic or cardiac symptoms (early disseminated LD), radiculoneuropathy or arthritis (late stage of LD)
attributed to this disease. Commercial Borrelia recombinant IgG ELISA (Biomedica Immunoassays, Bratislava, Slovakia) and in-house developed western blotting were used for confirmation of anti-Borrelia antibodies in patient sera and OspC positive sera were pooled. Serum samples from 5 healthy donors with no serological evidence of the LD were also included. Written informed consent was obtained from all donors.
Purification of total antibodies
The IgG´s from pooled patient sera were purified with hydrophobic interaction chromatography (MEP HyperCel, PALL Life Science, Vienna, Austria). Briefly, HyperCel sorbent was equilibrated with 50 mM Tris-HCl (pH 8.0) and incubated with 4 ml of serum for 1 hr at room temperature with gentle shaking. After three washings, bound antibodies were eluted under low pH conditions (50mM sodium acetate, pH 4.0).
Eluate was dialyzed against PBS and stored in 50% glycerol in PBS.
Production of recombinant OspC and BmpA
Whole OspC protein coding region was PCR amplified with F 5´-CGCGGATCCATGACTTTATTTTTATTTATATCTTGTAATAAT and R 5´-TATGTCGACAGGTTTTTTTGGACTTTCTGC primers from genomic DNA of Borrelia burgdorferi sensu stricto (strain SKT-2, accession number AY597021.1).
Amplicons were digested with BamHI and SalI restriction enzymes (Fermentas, Blue cells were transformed with ligated vector and transfomants were selected on 2xTY agar containing 0.1% glucose, 100 μg/ml ampicillin and 10 μg/ml tetracycline.
Integration of ospC fragments into the vector and their fusion with the gene encoding gp3 was examined in randomly picked colonies by PCR and direct sequencing using vector-specific primers (pSEX81 F 5´-ATGAAATACCTATTGCCTACGGCAG; pSEX81 R 5´-CTACAACGCCTGTAGCATTCCAC). After overnight incubation at 37°C bacterial colonies were counted and scrapped into the LB medium containing 50%
glycerol. An aliquot containing 10 12 cells representing each member of the library was used to inoculate 100 ml 2xTY medium containing 0.1% glucose, 100 μg/ml ampicillin and 10 μg/ml tetracycline. Mid-log phase culture (OD 600 0.6) was superinfected with
Hyperphage M13K07ΔpIII (PROGEN Biotechnik, Heidelberg, Germany) at a multiplicity of infection 20 and incubated at 37°C for one hour without shaking.
Bacteria were pelleted by centrifugation and resuspended in fresh 2xTY medium containing 100 μg/ml ampicillin and 10 μg/ml tetracyclin. The volume of the superinfected culture was 50% larger than that of the pre-infected culture. Infected bacteria were grown overnight at 30°C with shaking and cells were pelleted. Phage particles from the supernatant were concentrated by to two rounds of PEG-precipitation.
White pellet of the phage particles displaying OspC fragments was resuspended in buffer containing 10 mM TrisHCl, 20 mM NaCl and 2 mM EDTA (pH 7.5). Number of phage clones was calculated by colony forming units (CFU) on XL-1 Blue cells in 2xTY plates containing 50 µg/ml ampicillin and 10 µg/ml tetracyclin (2xTY/Amp/Tet plates) as described before [17] .
Selection (panning) of phages interacting with anti-OspC antibody
Anti-OspC antibodies were captured on Ezview Red Protein G Affinity beads (Sigma Aldrich, Bratislava, Slovakia) according to manufacturer's instructions. Beads were washed two times with sterile PBS and 200 μl (1 x 10 11 ) of the phages carrying OspC fragments were resupended in buffer containing 10 mM TrisHCl, 20 mM NaCl and 2 mM EDTA (pH 7.5) were added and incubated for 1 h with gentle shaking. Beads were washed with PBS for at least 10 times. Bound phages were eluted in 500 μl of trypsin (10μg/ml) in PBS for 30 min at 37°C with gentle shaking. Number of eluted phages were calculated by CFU on XL-1 Blue cells in 2xTY plates containing 50 µg/ml ampicillin and 10 µg/ml tetracyclin (2xTY/Amp/Tet plates) as described before [17] . afzelii (strain PKo -X62162 and ACA1 -L42892.1), were retrieved from GenBank repository and in silico translated. These sequences were aligned with epitopes using
Genious software (Biomatters, San Francisco, USA).
RESULTS
Antigen affinity purification and characterization of anti-OspC antibodies
Thirteen serum samples from the patients in early stage LD and early dissemination LD were chosen for total antibody purification based upon the results of ELISA and western blot used to confirm anti-Borrelia antibodies (data not shown). Serum IgG were purified using the hydrophobic interaction chromatography. To ensure the purity of IgG, small aliquot was fractionated on SDS PAGE ( 
Library construction and panning
In order to determine the amino acid sequences recognized by the anti-OspC antibody (OspC epitope mapping), a library of random fragments of the ospC gene was constructed using a phagemid vector pSEX81. The size of the ospC fragment display library was 6x10 9 and the length of fragments was maximum 75 bp (Fig. 3 SuppInfo) .
Thus, a chain of maximum 25 aa of OspC was fused to the major coat protein pIII and displayed on M13KO7 filamentous phage through two-gene phagemid system. A library was incubated with affinity purified anti-OspC antibody to select immunoreactive phage clones. Phage clones escaped from individual E. coli clone were used in FLISA to confirm their affinity to anti-OspC antibody. Out of twenty randomly picked clones, sixteen phages showed strong affinity to anti-OspC antibody (P < 0.01, Fig. 1 ). Whereas, binding ability of C1, C4, C19 and C20 was weak (statistically insignificant when compared to negative control P > 0.01, Fig. 1 ) and were not included in further analysis.
Epitope identification and characterization
The ospC gene fragments from XL-1 blue clones, except C1, C4, C19 and C20, were amplified with vector specific primers (Fig. 4 SuppInfo), sequenced, translated in silico and aligned with the amino acid sequence of OspC to map the epitopes. We found six immunoreactive regions on the OspC (Fig. 2 and Table 1 ). Three OspC fragments were aligned with a common stretch of 9 residues (CNNSGKDGN; OspC E1), two were aligned with a common stretch of 5 residues (VETLL; OspC E3). At the C-terminus of OspC, three fragments were overlapped with AKKAILKTH (OspC E4), four peptides had a common sequence of 7 residues LKAAKEM (OspC E5) and three peptides overlapped with PVVAESP region (OspC E6). A single peptide was aligned with 16 amino acid stretch KPNLVEISKKITDSN (OspC E2) ( Fig. 2 and Table 1 ).
Distinguishing between continuous and discontinuous epitopes is an important step in epitope mapping. It is accepted that discontinuous epitopes is unrecognized by antibodies in western blot due protein denaturation [17] . To determine whether the epitopes mapped by us are linear or conformational, epitopes were overexpressed and used in the western blot against pooled patient serum. The results confirmed that OspC peptides C10, C14, C2, C12 and C7 are the immunoreactive sites on OspC and may represent linear epitopes (Fig. 3) . Absence of reactivity of C9 in western blot may suggest discontinuous character of this potential epitope.
To be effective within the constraints of an immunization, an epitope must be highly conserved. Variation in immunodominant epitopes/antigens used in immunization often fail to generate cross-reactive antibodies. Multiple sequence alignment (MSA) of OspC from 7 European Borrelia genospecies is presented in Figure   4 . MSA showed conservation of CNNSG motif within OspC E1, while four residues KDGN (aa 24-27) were hypervariable. OspC E2, the longest epitope found in our study, was relatively conserved (consensus linear pattern KGPNL and ISKKITDSN). In contrast, epitope OspC E3 and E5 were the most variable epitopes. Sequence variability of OspC E3 was observed even within the same genospecies. OspC E6, the C-terminal epitope, was the most conserved among all immunoreactive regions found in the study.
The consensus linear pattern PVVAESP was found in all analyzed OspCs, except in PBr (Fig. 4) .
DISCUSSION
A plethora of outer surface proteins of B. burgdorferi have been shown to induce a protective immune response in animal models [18] . Previously, it was reported that Borrelia rapidly upregulates expression of OspC within the first hours of tick attachment on the host [3] . OspC is required for survival of Borrelia during the early stages of borrelial infection. It is hypothetized that OspC binds a mammalian-derived ligands presented in the blood, extracellular fluid or tissues to evade host immune response [19, 7, 20] . Borreliacidal anti-OspC antibodies are formed shortly after infection. High concentration of borreliacidal antibodies specific for a region near Nterminus (the first helix) have been demonstrated in sera from patients with early LD [21] . In another report, it has been shown that borreliacidal OspC antibodies are predominantly IgM type with specificity for epitope(s) within the 50 amino acids residues located at C-terminus [22] .
Hitherto, full length or truncated proteins have been used as antigens in serodiagnosis of LD, however, non-specificity remains a major issue [23, 24] . OspC E6. Of the six identified epitopes, OspC E1 located at the N-terminus and OspC E4 and OspC E6 both located at C-terminus, were highly conserved among the different OspC orthologs (Fig. 4) and capable of distinguishing between LD patient and healthy control sera (Fig. 3) .
Till to date, few works were focused to identify epitopes on OspC using truncated proteins [25] [26] [27] [28] . These studies have attempted to identify both conformational and linear epitopes. Two epitopes located at N-terminus (aa 20-35 and aa 35-55) of OspC recognized by monoclonal antibodies have been determined [28] .
Furthermore, N-terminal peptide 11 30 was suggested as an epitope in serodiagnostic assay for diagnosis of early LD [25] . In our study we found that only nine amino acid stretch ) is conserved and has been shown to be essential for dimerization via formation of an intermolecular disulfide bridge resulting in higher OspC dimer-IgM affinity compared to monomer [29] . Epitope OspC E2 (   38   KGPNLVEISKKITDSN   53 ) mapped in our study corresponds with the antibody binding domain (aa35-55) identified previously with OspC-specific monoclonal antibodies [28] . This epitope appears to be conformational because its immunoreactivity was lost when linearized on SDS-PAGE and then incubated with anti-OspC antibody in western blotting (Fig. 3) . Epitope OspC E3 (   62   VETLL   66 ) was found to be located in ligand binding domain LBD1, which binds a mammalian-derived ligands [19, 7, 20] .
MTLFLFISCNNSGKDGNTSA
The C-terminal decapeptide PVVAESPKKP (commercially available as PepC10) is used to detect anti-OspC IgM in patient's sera in serodiagnostic tests [26, 30] . In the study presented by Arnaboldi and colleages, the peptide PepC10 detected antibody in only 48 of 98 serum samples (49.0%) and generated false-positive results among negative healthy and diseased controls [25] . This region adopts highly conserved polyproline II-like helix motif (PKKP), which is common to various surface-exposed structures involved in protein-protein interactions [26] . OspC E6 epitope found in our study lacks PXXP motif, which suggests that polyproline II-like helical structure is not Despite the strong conservation of OspC N-and C-terminal domains, the antibody responses to the OspC types were found to be type specific, which suggests that the immunodominant linear OspC epitopes reside in the variable domains (i.e., type-specific domains) of the protein [27] . The region spanning residues 136 to 150
(termed as loop 5 epitope) and 168 to 210 (termed alpha 5 epitope) were identified as anti-OspC antibody binding sites responsible for high type specificity of antibody response to OspC. The loop 5 is surface exposed in both the mono-and dimeric models of OspC [7] . OspC E4 residues of alpha 5 [27] . The OspC E5 represents the variable part of alpha 5 epitope. In silico analysis of the linear sequence and 3-dimensional structure of OspC pointed the fifth C-terminal helix (residue 179 to 188) as a major determinant of type-specific antibody binding site [31] . The five residues of OspC E5 (residue 184-191) may constitute a minimal region determining antibody specificity.
In this study we mapped minimal potential epitopes, reacting with antibodies from naturally infected LD patients. Use of these minimal B-cell epitopes could overcome the issues associated with cross-reactivity and non-specificity frequently observed in the serodiagnosis of LD and may help to develop epitope-based vaccines. burgdorferi sensu stricto (strain SKT-2) was amplified (lane 1) and fragmented using Dnase I (lane 2). Fragments <75 bp were gel purified (dashed rectangle). 
